Impact of a Guideline-Based Disease Management Team on Outcomes of Hospitalized Patients With Congestive Heart Failure
Open Access
- 22 January 2001
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 161 (2) , 177-182
- https://doi.org/10.1001/archinte.161.2.177
Abstract
IN THE UNITED STATES, congestive heart failure (CHF) is the leading discharge diagnosis by diagnosis related group, accounting for nearly 1 million hospitalizations and causing 200 000 deaths each year.1 Annual expenditures for CHF are estimated to be $38 billion, of which $23 billion is for inpatient care.2 Medicare expenditures for CHF exceed those for acute myocardial infarction and cancer combined.Keywords
This publication has 2 references indexed in Scilit:
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987